ConductScience.org, home
Papers
API referenceFor AI assistants

Paper · 20022054

The miR-17-92 cluster is over expressed in and has an oncogenic effect on renal cell carcinoma.

Chow TF and 11 others. J Urol, 2010. Cited by 128 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. The miR-17-92 cluster is over expressed in and has an oncogenic effect on renal cell carcinoma. Papers, record 20022054. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/20022054

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The miR-17-92 cluster is over expressed in and has an oncogenic effect on renal cell carcinoma.
PubMed
Journal
J Urol
PubMed
Year
2010
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
128
iCite
Relative citation ratio, by iCite
2.88
iCite
Revised in PubMed
2022-04-09
PubMed

Authors12

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Chow TFTsz-Fung F
2Mankaruos MMarina
3Scorilas AAndreas
4Youssef YYoussef
5Girgis AAndrew
6Mossad SSarah
7Metias SShereen
8Rofael YYostina
9Honey RJR John
10Stewart RRobert

1 to 10 of 12Source PubMed

See all 12 authors

Topics5

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Carcinoma, Renal CellMajor topic
Gene Expression Regulation, NeoplasticMajor topic
Kidney NeoplasmsMajor topic
MicroRNAsMajor topic
Humans

Source PubMed

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
86490Canadian Institutes of Health ResearchCanadaPubMed

Source PubMed

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References0

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

None in this release.

Cited by83

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 128 citations.

PMIDTitleJournalYearIn PapersSource
40,537,745The MAP kinase negative regulator DUSP2 (dual specificity phosphatase 2) is controlled by oncogenic microRNA cluster miR-17-92, miR-106a-363 and miR-106b-25.BMC Cancer2025https://conductscience.org/library/papers/40537745PubMed
38,036,953Comprehensive analysis of miRNA-mRNA regulatory pairs associated with colorectal cancer and the role in tumor immunity.BMC Genomics2023https://conductscience.org/library/papers/38036953PubMed
37,161,350The role of noncoding RNAs in metabolic reprogramming of cancer cells.Cell Mol Biol Lett2023https://conductscience.org/library/papers/37161350PubMed
36,497,215The Underestimated Role of the p53 Pathway in Renal Cancer.Cancers (Basel)2022https://conductscience.org/library/papers/36497215PubMed
36,164,575Recent advances in mitochondrial diseases: From molecular insights to therapeutic perspectives.Saudi Pharm J2022https://conductscience.org/library/papers/36164575PubMed
36,064,348MicroRNA-18a regulates the metastatic properties of oral squamous cell carcinoma cells via HIF-1α expression.BMC Oral Health2022https://conductscience.org/library/papers/36064348PubMed
36,013,278MicroRNAs as Regulators of Cancer Cell Energy Metabolism.J Pers Med2022https://conductscience.org/library/papers/36013278PubMed
35,532,070Angiotensin (1-7) protects against renal ischemia-reperfusion injury via regulating expression of NRF2 and microRNAs in Fisher 344 rats.Am J Physiol Renal Physiol2022https://conductscience.org/library/papers/35532070PubMed
34,968,247One Omics Approach Does Not Rule Them All: The Metabolome and the Epigenome Join Forces in Haematological Malignancies.Epigenomes2021https://conductscience.org/library/papers/34968247PubMed
33,920,158Modeling Neoplastic Growth in Renal Cell Carcinoma and Polycystic Kidney Disease.Int J Mol Sci2021https://conductscience.org/library/papers/33920158PubMed

1 to 10 of 83

See all 83 cited by

Genes7

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
MIR17406,952PubTator's text mininghttps://conductscience.org/library/genes/406952NCBI Gene
MIR17HG407,975PubTator's text mininghttps://conductscience.org/library/genes/407975NCBI Gene
MIR20A406,982PubTator's text mininghttps://conductscience.org/library/genes/406982NCBI Gene
MIR9-2407,047PubTator's text mininghttps://conductscience.org/library/genes/407047NCBI Gene
MTOR2,475PubTator's text mininghttps://conductscience.org/library/genes/2475NCBI Gene
VEGFA7,422PubTator's text mininghttps://conductscience.org/library/genes/7422NCBI Gene
VHL7,428PubTator's text mininghttps://conductscience.org/library/genes/7428NCBI Gene

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/20022054

GET https://conductscience.org/api/papers/v1/20022054/cited_by?page=2

API referenceFor AI assistants